Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92


The HuR CMLD-2 inhibitor exhibits antitumor effects via MAD2 downregulation in thyroid cancer cells.

Allegri L, Baldan F, Roy S, Aubé J, Russo D, Filetti S, Damante G.

Sci Rep. 2019 May 14;9(1):7374. doi: 10.1038/s41598-019-43894-0.


Expression of Leptin Receptor and Effects of Leptin on Papillary Thyroid Carcinoma Cells.

Celano M, Maggisano V, Lepore SM, Sponziello M, Pecce V, Verrienti A, Durante C, Maranghi M, Lucia P, Bulotta S, Damante G, Russo D.

Int J Endocrinol. 2019 Feb 14;2019:5031696. doi: 10.1155/2019/5031696. eCollection 2019.


Secoiridoids of olive and derivatives as potential coadjuvant drugs in cancer: A critical analysis of experimental studies.

Celano M, Maggisano V, Lepore SM, Russo D, Bulotta S.

Pharmacol Res. 2019 Apr;142:77-86. doi: 10.1016/j.phrs.2019.01.045. Epub 2019 Feb 14. Review.


Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells.

Maggisano V, Celano M, Lepore SM, Sponziello M, Rosignolo F, Pecce V, Verrienti A, Baldan F, Mio C, Allegri L, Maranghi M, Falcone R, Damante G, Russo D, Bulotta S.

Endocrine. 2019 Mar;63(3):545-553. doi: 10.1007/s12020-018-01836-2. Epub 2019 Jan 19.


Reading Cancer: Chromatin Readers as Druggable Targets for Cancer Treatment.

Mio C, Bulotta S, Russo D, Damante G.

Cancers (Basel). 2019 Jan 9;11(1). pii: E61. doi: 10.3390/cancers11010061. Review.


A synonymous RET substitution enhances the oncogenic effect of an in-cis missense mutation by increasing constitutive splicing efficiency.

Pecce V, Sponziello M, Damante G, Rosignolo F, Durante C, Lamartina L, Grani G, Russo D, di Gioia CR, Filetti S, Verrienti A.

PLoS Genet. 2018 Oct 15;14(10):e1007678. doi: 10.1371/journal.pgen.1007678. eCollection 2018 Oct.


Antiproliferative Effects of Cynaropicrin on Anaplastic Thyroid Cancer Cells.

Lepore SM, Maggisano V, Lombardo GE, Maiuolo J, Mollace V, Bulotta S, Russo D, Celano M.

Endocr Metab Immune Disord Drug Targets. 2019;19(1):59-66. doi: 10.2174/1871530318666180928153241.


Effects of Oleacein on High-Fat Diet-Dependent Steatosis, Weight Gain, and Insulin Resistance in Mice.

Lombardo GE, Lepore SM, Morittu VM, Arcidiacono B, Colica C, Procopio A, Maggisano V, Bulotta S, Costa N, Mignogna C, Britti D, Brunetti A, Russo D, Celano M.

Front Endocrinol (Lausanne). 2018 Mar 19;9:116. doi: 10.3389/fendo.2018.00116. eCollection 2018.


Anti-hTERT siRNA-Loaded Nanoparticles Block the Growth of Anaplastic Thyroid Cancer Xenograft.

Lombardo GE, Maggisano V, Celano M, Cosco D, Mignogna C, Baldan F, Lepore SM, Allegri L, Moretti S, Durante C, Damante G, Fresta M, Russo D, Bulotta S, Puxeddu E.

Mol Cancer Ther. 2018 Jun;17(6):1187-1195. doi: 10.1158/1535-7163.MCT-17-0559. Epub 2018 Mar 21.


Secretome Analysis of Hypoxia-Induced 3T3-L1 Adipocytes Uncovers Novel Proteins Potentially Involved in Obesity.

Laria AE, Messineo S, Arcidiacono B, Varano M, Chiefari E, Semple RK, Rocha N, Russo D, Cuda G, Gaspari M, Brunetti A, Foti DP.

Proteomics. 2018 Apr;18(7):e1700260. doi: 10.1002/pmic.201700260.


Effects of HuR downregulation on anaplastic thyroid cancer cells.

Allegri L, Mio C, Russo D, Filetti S, Baldan F.

Oncol Lett. 2018 Jan;15(1):575-579. doi: 10.3892/ol.2017.7289. Epub 2017 Oct 30.


Identification of Thyroid-Associated Serum microRNA Profiles and Their Potential Use in Thyroid Cancer Follow-Up.

Rosignolo F, Sponziello M, Giacomelli L, Russo D, Pecce V, Biffoni M, Bellantone R, Lombardi CP, Lamartina L, Grani G, Durante C, Filetti S, Verrienti A.

J Endocr Soc. 2017 Jan 12;1(1):3-13. doi: 10.1210/js.2016-1032. eCollection 2017 Jan 1.


BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells.

Mio C, Conzatti K, Baldan F, Allegri L, Sponziello M, Rosignolo F, Russo D, Filetti S, Damante G.

Oncol Rep. 2018 Feb;39(2):582-588. doi: 10.3892/or.2017.6152. Epub 2017 Dec 12.


Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer.

Sponziello M, Benvenuti S, Gentile A, Pecce V, Rosignolo F, Virzì AR, Milan M, Comoglio PM, Londin E, Fortina P, Barnabei A, Appetecchia M, Marandino F, Russo D, Filetti S, Durante C, Verrienti A.

Hum Mutat. 2018 Mar;39(3):371-377. doi: 10.1002/humu.23378. Epub 2017 Dec 20.


MicroRNAs as Biomarkers in Thyroid Carcinoma.

Celano M, Rosignolo F, Maggisano V, Pecce V, Iannone M, Russo D, Bulotta S.

Int J Genomics. 2017;2017:6496570. doi: 10.1155/2017/6496570. Epub 2017 Sep 6. Review.


Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches.

Baldan F, Mio C, Allegri L, Passon N, Lepore SM, Russo D, Damante G.

Minerva Endocrinol. 2018 Sep;43(3):285-293. doi: 10.23736/S0391-1977.17.02735-3. Epub 2017 Sep 7. Review.


Targeting post-translational histone modifications for the treatment of non-medullary thyroid cancer.

Celano M, Mio C, Sponziello M, Verrienti A, Bulotta S, Durante C, Damante G, Russo D.

Mol Cell Endocrinol. 2018 Jul 5;469:38-47. doi: 10.1016/j.mce.2017.05.036. Epub 2017 Jun 2. Review.



Chiarella G, Russo D, Monzani F, Petrolo C, Fattori B, Pasqualetti G, Cassandro E, Costante G.

Endocr Pract. 2017 Jul;23(7):863-868. doi: 10.4158/EP161635.RA. Epub 2017 May 23. Review.


Impact of legumes and plant proteins consumption on cognitive performances in the elderly.

Mazza E, Fava A, Ferro Y, Moraca M, Rotundo S, Colica C, Provenzano F, Terracciano R, Greco M, Foti D, Gulletta E, Russo D, Bosco D, Pujia A, Montalcini T.

J Transl Med. 2017 May 22;15(1):109. doi: 10.1186/s12967-017-1209-5.


MicroRNA-based molecular classification of papillary thyroid carcinoma.

Rosignolo F, Memeo L, Monzani F, Colarossi C, Pecce V, Verrienti A, Durante C, Grani G, Lamartina L, Forte S, Martinetti D, Giuffrida D, Russo D, Basolo F, Filetti S, Sponziello M.

Int J Oncol. 2017 May;50(5):1767-1777. doi: 10.3892/ijo.2017.3960. Epub 2017 Apr 7.


Supplemental Content

Loading ...
Support Center